2014

2012

2011

2010

31/12/10 - Updated Share Trading Policy

01/12/10 - Results of Meeting - 2010 AGM

30/11/10 - Chairman`s Address to Shareholders - 2010 AGM

16/11/10 - Notice of Annual General Meeting/Proxy Form

10/11/10 - Response to ASX Query - Appendix 4C

28/10/10 - Annual Report to shareholders - Erratum

28/10/10 - Annual Report to shareholders - Directors` Declaration

28/10/10 - Annual Report to shareholders

27/10/10 - Appendix 4C - quarterly

01/10/10 - Appendix 3B

29/09/10 - Full Year Statutory Accounts-FY10

31/08/10 - Preliminary Final Report - FY2010

31/08/10 - RedHill Completion

17/08/10 - Disclosure Document - Red Hill Sale

11/08/10 - ASX Appendix 4C query and response

02/08/10 - Disclosure Document - 4C for FY10

02/07/10 - Change of Director`s Interest Notice Borody Form 604

01/07/10 - Change of Director`s Interest Notice - McLean 3Y

01/07/10 - Change of Director`s Interest Notice - Borody

16/06/10 - AMTI Termination

16/06/10 - Proposed Sale of Intellectual Property

24/05/10 - Appendix 4C Query and Response

17/05/10 - Disclosure Document - AMTI Completion
03/05/10 - Appendix 4C - quarterly

23/04/10 - Disclosure Document - Heliconda License

19/04/10 - Disclosure Document - Asset Purchase Update

19/04/10 - Disclosure Document - Patent Status

01/04/10 - Appendix 3B

19/03/10 - Disclosure Document - AMTI Asset Purchase Delay

09/03/10 - Disclosure Document - Asset and Share Sale Update 

02/03/10 - Appendix 3B - Further Revisions

02/03/10 - Disclosure Document - Research Collaboration

22/02/10 - Appendix 3B Corrections

19/02/10 - Becoming a substantial holder

18/02/10 - Notice under Section 708A

18/02/10 - Sale of Myoconda and Share Placement

18/02/10 - Appendix 3B

6/02/10 - Half Yearly Report and Accounts

11/02/10 - Notice under Section 708A

09/02/10 - Details of Company Address

05/02/10 - Company Secretary Resignation

05/02/10 - Loan Facility Repayment

05/02/10 - Appendix 3B

02/02/10 - ASX Appendix 4C Query and Response

29/01/10 - Appendix 4C - quarterly

2009

2008

1/12/08 - AGM Results

1/12/08 - AGM Presentation

1/12/08 - AGM Chairman’s speech

31/10/08 - Share Subscription Agreement Termination and RestrictionAgreement Expiry

28/10/08 - Appendix 4C – Quarterly Report

28/10/08 - AGM Notice & Proxy Form

28/10/08 - Annual Report 08

23/10/08 - Chairman resignation

23/10/08 - Final Directors Interest Notice

1/9/08 - Appendix 4E Preliminary Final Report

5/8/08 - Change of Director’s Interest Notice

22/7/08 - Giaconda announces proposal for share placement

14/7/08 - Appendix 4C

9/7/08 - Giaconda Suspends Hepaconda® Phase II Trial
to Carry Out Dose Ranging
20/6/08 - Appendix 3Y Moore

20/6/08 - Appendix 3Y Moon

20/6/08 - Appendix 3Y Woods

20/6/08 - Appendix 3B

7/4/08 - Giaconda Receives European Patent for Myoconda®

11/3/08 - Half Year Report ended 31 Dec 2007

3/3/08 - Appendix 4D and Half Year Results

19/2/08 - Appendix 3Y (3)

19/2/08 - Appendix 3Y(2)

19/2/08 - Appendix 3Y (1)

19/2/08 - Appendix 3B

19/2/08 - Clinical Trial Pilot Results

8/2/08 - Giaconda has commenced next round of fundraising

29/1/08 - Appendix 4C

22/1/08 - Heliconda® Patent Granted

2007

6/11/07 - Appendix 4C

29/10/07 - AGM Chairman's Speech

29/10/07 - AGM CEO's Speech

29/10/07 - AGM CMO's Presentation

24/9/07 - Clinical Trial Clarification

19/9/07 - Giaconda Signs Agreement to Take Myoconda® to Market in Europe

14/9/07 - Release of restricted securities from escrow on 27.09.07 and Appendix 3B

11/9/07 - 2007 Notice of AGM, Explanatory Memorandum and Proxy Form

11/9/07 - 2007 Annual Report

3/9/07 - Giaconda Appoints New Company Secretary

3/9/07 - Intersuisse analyst report on Giaconda Limited

28/8/07 - FY07 Appendix 4E Preliminary Final Report

27/8/07 - Hepaconda gains recognition as a promising drug

17/8/07 - Giaconda – office relocation and personnel change

23/7/07 - July 2007 Presentation – Company Update to Analysts

19/7/07 - Appendix 4C, Commitments Test Entity – Fourth Quarter Report

19/7/07 - Appendix 3B – Issue of Shares

19/7/07 - Appendix 3Y – Change of Director’s Interest Notice (T. Moon)

19/7/07 - Appendix 3Y – Change of Director’s Interest Notice (T. Moore)

19/7/07 - Appendix 3Y – Change of Director’s Interest Notice (R. Woods)

18/7/07 - Australian study of anti-MAP treatment in Crohn’s Disease published showing highest ever remission rates
4/7/07 - Lapsed Employee Options

25/6/07 - Commencement of PhIIa clinical trial for Hepaconda® in Hepatitis C

7/5/07 - Giaconda appoints new COO

24/4/07 - FDA approves Myoconda® IND for MAP in Crohn’s Disease

18/4/07 - Commitments Test Entity – Third Quarter Report

4/4/07 - Appendix 3B (Issue of Shares)

4/4/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moon)

4/4/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moore)

4/4/07 - Appendix 3Y Change in Directors’ Interests Notice (R. Woods)

22/3/07 - Peer reviewed journal paper supports use of Giaconda’s lead product Myoconda® for Crohn’s Disease

19/2/07 - Appendix 3B (Issue of Shares)

19/2/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moore)

19/2/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moon)

19/2/07 - Appendix 3Y Change in Directors’ Interests Notice (R. Woods)

13/2/07 - Half-Year FY07 Results

13/2/07 - Half-Year Report and Half-Year Accounts ended 31 Dec 2006

9/2/07 - Corporate Governance – amendment to contingent liabilities

18/1/07 - Commitments Test Entity – Second Quarter FY07

2006

28/12/06 - Giaconda receives European patent for Ibaconda

22/12/06 - Clarification of Options issued by Giaconda

22/12/06 - Appendix 3B (Issue of Shares)

22/12/06 - Appendix 3X Initial Director’s Interest Notice (T. Moore)

22/12/06 - Appendix 3Y Change in Director's Interests Notice (A. Moon)

22/12/06 - Appendix 3Y Change in Director's Interests Notice (R. Woods)

19/12/06 - Newsletter Issue 2 – December 2006

9/11/06 - Giaconda receives European patent for Heliconda®

31/10/06 - Results of 2006 AGM

30/10/06 - Chairman’s Address at AGM to Shareholders

30/10/06 - CEO’s Speech at AGM

30/10/06 - CMO’s Presentation at AGM

24/10/06 - Giaconda announces Myoconda® poster presentation at American College of Gastroenterology meeting

19/10/06 - Commitments Test Entity – First Quarter FY07

18/10/06 - Giaconda announces positive Phase II data for Picoconda presented at AGW

17/10/06 - Giaconda signs non-binding letter of intent for Myoconda® active ingredient

28/9/06 - 2006 Annual Report

28/9/06 - Notice of 2006 AGM

26/9/06 - Giaconda signs non-binding letter of intent for Myoconda®commercialisation in Benelux territory

14/9/06 - Appendix 4E Preliminary Final Report
14/9/06 - Financial year ends with a positive outlook for 2007

24/8/2006 - Appendix 3Z - Final Director's Interest Notice

23/8/2006 - Giaconda appoints new Chairman

17/8/2006 - Appendix 3B - Issue of Options

01/08/2006 - Change of Director’s Interest Notice

01/08/2006 - Second Non-binding Loi for Commercialisation of Myoconda®

28/07/2006 - Commitments Test Entity – Fourth Quarter

28/07/2006 - Cessation/Appointment of Company Secretary

27/06/2006 - ASX Announcement of June 2006 Roadshow

19/05/2006 - Signs Service Agreement with CDD for Prof Borody

25/04/2006 - Commitments Test Entity - Third Quarter Report

13/04/2006 - Non-binding commercialisation LOI for Myoconda®® in UK

10/03/2006 - Newsletter Issue 1

10/03/2006 - Half Yearly Report and Half Year Accounts ended 31 Dec 2005

09/03/2006 - Hepaconda Patent Update

28/02/2006 - Amended initial Director's Interest Notice

06/02/2006 - Giaconda signs LOI with ICON for Myoconda® Phase IIIb study

06/02/2006 - Appendix 3B - Issue of options

31/01/2006 - Second Quarter Report

30/01/2006 - Heliconda Phase II study results published

18/01/2006 - Myoconda® Phase II study update

17/01/2006 - First Scientific Advisory Board Meeting held

2005

21/12/2005 - Appointment of Asst Company Secretary & CAO

14/12/2005 - Giaconda meets FDA & MHRA supported by BioBusiness Grant

30/11/2005 - Holds First AGM

23/11/2005 - Supplement to Results of AGM

18/11/20005 - Results of AGM

13/10/2005 - AGM Notice 2005

13/10/2005 - Signed Full 2005 Accounts

06/10/2005 - Amended Initial Director's Interest Notice

05/10/2005 - Initial Director's Interest Notice x6

04/10/2005 - Nobel Prize Confirms Giaconda's Direction

26/09/2005 - Company Secretary Resignation/Appointment

23/09/2005 - Terms & conditions of options to Messrs Allen & Hare
23/09/2005 - Securities subject to escrow & voluntary escrow

23/09/2005 - Appendix 1A - ASX Listing application & agreement

23/09/2005 - Constitution

23/09/2005 - Audited accounts for year ended 30 June 2004

23/09/2005 - Audited accounts for year ended 30 June 2005

23/09/2005 - Updated Statement of Commitment

23/09/2005 - Top 20 shareholders

23/09/2005 - Distribution Schedule

23/09/2005 - Pre-Quotation Disclosure

23/09/2005 - ASX Circular: Commencement of Official Quotation

23/09/2005 - Admission to Official List